EnteroMedics Announces Reduction in Workforce - MarketWatch
EnteroMedics Announces Reduction in Workforce MarketWatch - 3 hours ago EnteroMedics has met its enrollment goal under an FDA-approved Investigational Device Exemption (IDE) for the EMPOWER Study using the Maestro(TM) System, ...
Cell Movements Totally Modular, Stanford Study Shows - MarketWatch
Cell Movements Totally Modular, Stanford Study Shows MarketWatch - Nov 30, 2008 ... it will be easier to effectively modify the system to change cell behaviors and ultimately treat human disease." This study was funded by the National ...